Clincosm LogoSign in Get a demo

adverse events

Showing 1 - 21 of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Airway Complication of Anesthesia, Adverse Events Trial in Germany, Switzerland

Not yet recruiting
  • Airway Complication of Anesthesia
  • Adverse Events
    • Berlin, Germany
    • +3 more
    Oct 30, 2023

    Plasmapheresis, Haematology, Sport Performance Trial in Louvain-la-Neuve (Plasmapheresis)

    Completed
    • Plasmapheresis
    • +6 more
    • Plasmapheresis
    • Louvain-la-Neuve, Brabant Wallon, Belgium
      UCLouvain
    Apr 3, 2023

    Bonding, Stress, Breastfeeding Trial in Linkoping (Delayed cord clamping and early skin-to-skin contact)

    Recruiting
    • Bonding
    • +4 more
    • Delayed cord clamping and early skin-to-skin contact
    • Linkoping, Sweden
      Crown Princess Victoria children´s hopsital
    Jan 23, 2023

    Adverse Airway Events in High Risk Patients Undergoing Upper GI

    Active, not recruiting
    • SEDLine
    • +3 more
      • Philadelphia, Pennsylvania
        Hospital of the University of pennsylvania
      Nov 28, 2022

      Proficiency-based Progression Communication Training Programme

      Recruiting
      • Adverse Events
      • A team, proficiency based progression, simulation training programme
      • Cork, Ireland
      • +1 more
      May 23, 2022

      Adverse Events Trial in United States (Irrisept, Standard of Care)

      Completed
      • Adverse Events
      • Irrisept
      • Standard of Care
      • Tucson, Arizona
      • +16 more
      May 4, 2022

      Cervical Carcinoma, Chemoradiotherapy, Anti-programmed Cell Death Receptor 1 Trial in Beijing (Camrelizumab plus Concurrent

      Recruiting
      • Cervical Carcinoma
      • +8 more
      • Camrelizumab plus Concurrent chemoradiotherapy
      • Beijing, Beijing, China
        Lei Li
      Apr 5, 2022

      Ovarian Carcinoma, Survival Outcomes, Adverse Events Trial in Beijing (Niraparib plus anlotinib)

      Recruiting
      • Ovarian Carcinoma
      • +8 more
      • Niraparib plus anlotinib
      • Beijing, Beijing, China
        Lei Li
      Apr 5, 2022

      Ovarian Carcinoma, Platinum-resistant Ovarian Cancer, Recurrent Ovarian Carcinoma Trial in Beijing (Albumin-bound paclitaxel and

      Recruiting
      • Ovarian Carcinoma
      • +6 more
      • Albumin-bound paclitaxel and bevacizumab
      • Beijing, Beijing, China
        Lei Li
      Mar 26, 2022

      Spine Deformity, Bone Graft; Complications, Adverse Events Trial in Copenhagen (ABM/P-15 bone graft)

      Recruiting
      • Spine Deformity
      • +2 more
      • ABM/P-15 bone graft
      • Copenhagen, Denmark
        Rigshospitalet, Department of Orthopedics, Spine Unit
      Feb 15, 2022

      Adverse Events, Readmissions, Patient Engagement Trial in Boston (Multi-Model Intensive Discharge Intervention)

      Completed
      Has Results
      • Adverse Events
      • +2 more
      • Multi-Model Intensive Discharge Intervention
      • Boston, Massachusetts
      • +1 more
      Aug 9, 2019

      Efficacy and Safety on the Use of Bisphosphonates in Paediatrics

      Completed
      • Bone Fragile
      • +3 more
      • No intervention, observational study
      • Nîmes, France
        CHUNimes
      Jul 8, 2019

      Adverse Events Trial in Edmonton (Active Surveillance, Passive Surveillance)

      Completed
      • Adverse Events
      • Active Surveillance
      • Passive Surveillance
      • Edmonton, Alberta, Canada
        CARE
      Oct 24, 2017

      ReSure Sealant Post Approval Study

      Completed
      • Adverse Events
      • ReSure Sealant
      • (no location specified)
      Dec 2, 2016

      Quality of Telemedically Guided Prehospital Analgesia

      Completed
      • Analgesia
      • +9 more
      • physician operated telemedical prehospital analgesia
      • prehospital analgesia by on-scene EMS physicians
      • Aachen, Germany
        University Hospital Aachen
      Oct 6, 2016

      Treatment Response, Adverse Events, Feasibility Trial in Seoul (Photodynamic therapy)

      Unknown status
      • Treatment Response
      • +2 more
      • Photodynamic therapy
      • Seoul, Korea, Republic of
      • +1 more
      Apr 12, 2016

      Adverse Events, Pharmacokinetic Variables Trial in Evansville (ABT-143, ABT-335 and rosuvastatin)

      Completed
      • Adverse Events
      • Pharmacokinetic Variables
      • Evansville, Indiana
        Site Reference ID/Investigator# 11101
      Sep 27, 2012

      Adverse Events, Pharmacokinetic Trial in Orlando (ABT-143, ABT-335, Rosuvastatin)

      Completed
      • Adverse Events
      • Pharmacokinetic
      • Orlando, Florida
        Site Reference ID/Investigator# 8089
      Sep 27, 2012

      Adverse Events Trial in Santa Cruz de Tenerife (Group education, audit-feedback and computer support, Audit-feedback and

      Withdrawn
      • Adverse Events
      • Group education, audit-feedback and computer support
      • +2 more
      • Santa Cruz de Tenerife, Spain
        Servicio de Evaluación. Servicio Canario de Salud
      Sep 13, 2012

      Mortality, Hospitalization, Adverse Events Trial in Bissau (DTP3/4+OPV+MV versus OPV+MV or DTP4+OPV4 versus OPV4)

      Completed
      • Mortality
      • +2 more
      • DTP3/4+OPV+MV versus OPV+MV or DTP4+OPV4 versus OPV4
      • Bissau, Guinea-Bissau
        Bandim Health Project, Apartado 861
      Feb 25, 2012

      HER2-Overexpressed MBC Patients Treated by Cipterbin® Plus

      Completed
      • Progress-free Survival
      • +2 more
        • (no location specified)
        Feb 7, 2011